Verastem (VSTM) Accumulated Expenses (2011 - 2026)

Verastem's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 146.34% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was $7.9 million, a 146.34% increase from a year earlier, with the FY2025 full-year figure at $54.0 million, up 16982.59% from the prior year.
• Accumulated Expenses fell to $7.9 million in Q1 2026 per VSTM's latest filing, from $54.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $54.0 million in Q4 2025 and bottomed at $6000.0 in Q1 2022.
• The 5-year median for Accumulated Expenses is $3.6 million (2023), against an average of $9.9 million.
• Biggest YoY gain for Accumulated Expenses was 56450.0% in 2022; the steepest drop was 99.93% in 2022.
• Year by year, Accumulated Expenses stood at $3.8 million in 2022, then jumped by 366.39% to $17.9 million in 2023, then sank by 98.24% to $316000.0 in 2024, then surged by 16982.59% to $54.0 million in 2025, then sank by 85.35% to $7.9 million in 2026.
• Per Business Quant, the three latest VSTM Accumulated Expenses figures stand at $7.9 million (Q1 2026), $54.0 million (Q4 2025), and $7.8 million (Q3 2025).